Following Investor Meeting, Goldman Sachs Maintains Hansen PT

Following Hansen Natural Corp.'s HANS annual investor meeting in New York City, Goldman Sachs reports that the company discussed “the strength in their competitive position in the US where share gains continue, new product launches/line extensions driving incremental volume, and highlighted their efforts to build Monster internationally.” Goldman Sachs said that it came away from the meeting with several positive takeaways. As a result, it is maintaining its 12-month P/E (85%) and M&A (15%) based price target at $60. Hansen Natural Corp. closed Monday at $52.76.